We are live on
!
Find out more
RCA
Ranch Capital Advisors Portfolio holdings
AUM
$277M
1-Year Est. Return
22.08%
This Fund
S&P 500
This Quarter
Est. Return
+8.55%
1 Year Est. Return
+22.08%
3 Year Est. Return
+82.03%
5 Year Est. Return
+103.46%
10 Year Est. Return
–
AUM
$258M
AUM Growth
+$27.8M
(+12%)
Cap. Flow
+$10.9M
Cap. Flow
% of AUM
4.22%
Top 10 Holdings %
Top 10 Hldgs %
33.07%
Holding
158
New
16
Increased
82
Reduced
38
Closed
7
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medtronic
MDT
|
+$1.73M |
| 2 |
Pfizer
PFE
|
+$1.41M |
| 3 |
Vanguard Dividend Appreciation ETF
VIG
|
+$1.25M |
| 4 |
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
+$1.01M |
| 5 |
Vanguard S&P 500 ETF
VOO
|
+$740K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Oneok
OKE
|
+$1.58M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$1.39M |
| 3 |
Paychex
PAYX
|
+$817K |
| 4 |
Palo Alto Networks
PANW
|
+$706K |
| 5 |
CME Group
CME
|
+$533K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.76% |
| 2 | Financials | 9.09% |
| 3 | Healthcare | 7.4% |
| 4 | Communication Services | 5.59% |
| 5 | Utilities | 4.68% |
Similar funds
IIA
TAP
TLA
1NWS
RFA
EFP
AA
CCP
Ranch Capital Advisors's Q3 2025 Portfolio in Review
As of Q3 2025, Ranch Capital Advisors held 158 positions worth $258M, up 12% from $231M the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Ranch Capital Advisors deployed $10.9M of net new capital in Q3 2025, opening 16 new positions and adding to 82 existing holdings. Its largest new stake was Medtronic: 18,836 shares worth $1.8M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $1.39M trimmed.
- Ranch Capital Advisors's largest Q3 2025 buy was Medtronic: 18,836 shares worth $1.8M.
- Ranch Capital Advisors added most to Pfizer in Q3 2025, an estimated $1.41M increase.
- Ranch Capital Advisors's biggest Q3 2025 reduction was Bristol-Myers Squibb, cutting an estimated $1.39M.
- Ranch Capital Advisors fully exited Oneok in Q3 2025, selling an estimated $1.58M.
- Ranch Capital Advisors's ten largest holdings make up 33% of its $258M portfolio in Q3 2025.
- Ranch Capital Advisors opened 16 new positions and closed 7 in Q3 2025.
- Ranch Capital Advisors's portfolio value rose 12% quarter-over-quarter to $258M.
Based on Ranch Capital Advisors's 13F filing for Q3 2025, filed 14 Nov 2025.